2016

EMA is evaluating Moderna’s COVID-19 vaccine for children aged 6 to 11

| 12 November 2021 |

Moderna has submitted an application to the European Medicines Agency, EMA, to extend its conditional authorisation for its COVID-19 vaccine, Spikewax, to children aged 6 to 11.
2021 deadline for submitting applications concerning marketing authorisations and clinical trials

| 08 November 2021 |

The deadline for submitting applications concerning marketing authorisations and clinical trials is December 20 th The Danish Medicines Agency is closed for the Holiday Season, from December 24
The Danish Medicines Agency's guideline on extraordinary measures for clinical trials due to COVID-19 will not be extended after 01 December 2021

| 04 November 2021 |

We have chosen not to extend the validity of our guidance on extraordinary measures for clinical trials due to COVID-19 further, why the guidance and the granted exemptions expire on 01 December 2021.

Share by mail